120 related articles for article (PubMed ID: 18423488)
21. An antibody loop replacement design feasibility study and a loop-swapped dimer structure.
Clark LA; Boriack-Sjodin PA; Day E; Eldredge J; Fitch C; Jarpe M; Miller S; Li Y; Simon K; van Vlijmen HW
Protein Eng Des Sel; 2009 Feb; 22(2):93-101. PubMed ID: 19074157
[TBL] [Abstract][Full Text] [Related]
22. De novo design of antibody complementarity determining regions binding a FLAG tetra-peptide.
Entzminger KC; Hyun JM; Pantazes RJ; Patterson-Orazem AC; Qerqez AN; Frye ZP; Hughes RA; Ellington AD; Lieberman RL; Maranas CD; Maynard JA
Sci Rep; 2017 Aug; 7(1):10295. PubMed ID: 28860479
[TBL] [Abstract][Full Text] [Related]
23. Length of the antibody heavy chain complementarity determining region 3 as a specificity-determining factor.
Barrios Y; Jirholt P; Ohlin M
J Mol Recognit; 2004; 17(4):332-8. PubMed ID: 15227640
[TBL] [Abstract][Full Text] [Related]
24. Improving antibody binding affinity and specificity for therapeutic development.
Bostrom J; Lee CV; Haber L; Fuh G
Methods Mol Biol; 2009; 525():353-76, xiii. PubMed ID: 19252851
[TBL] [Abstract][Full Text] [Related]
25. Fab MOR03268 triggers absorption shift of a diagnostic dye via packaging in a solvent-shielded Fab dimer interface.
Hillig RC; Urlinger S; Fanghänel J; Brocks B; Haenel C; Stark Y; Sülzle D; Svergun DI; Baesler S; Malawski G; Moosmayer D; Menrad A; Schirner M; Licha K
J Mol Biol; 2008 Mar; 377(1):206-19. PubMed ID: 18241888
[TBL] [Abstract][Full Text] [Related]
26. Epitope mapping of anti-interleukin-13 neutralizing antibody CNTO607.
Teplyakov A; Obmolova G; Wu SJ; Luo J; Kang J; O'Neil K; Gilliland GL
J Mol Biol; 2009 May; 389(1):115-23. PubMed ID: 19361524
[TBL] [Abstract][Full Text] [Related]
27. Generation of high-affinity human antibodies by combining donor-derived and synthetic complementarity-determining-region diversity.
Hoet RM; Cohen EH; Kent RB; Rookey K; Schoonbroodt S; Hogan S; Rem L; Frans N; Daukandt M; Pieters H; van Hegelsom R; Neer NC; Nastri HG; Rondon IJ; Leeds JA; Hufton SE; Huang L; Kashin I; Devlin M; Kuang G; Steukers M; Viswanathan M; Nixon AE; Sexton DJ; Hoogenboom HR; Ladner RC
Nat Biotechnol; 2005 Mar; 23(3):344-8. PubMed ID: 15723048
[TBL] [Abstract][Full Text] [Related]
28. Germline humanization of a non-human primate antibody that neutralizes the anthrax toxin, by in vitro and in silico engineering.
Pelat T; Bedouelle H; Rees AR; Crennell SJ; Lefranc MP; Thullier P
J Mol Biol; 2008 Dec; 384(5):1400-7. PubMed ID: 18976662
[TBL] [Abstract][Full Text] [Related]
29. Structure of an anti-cholera toxin antibody Fab in complex with an epitope-derived D-peptide: a case of polyspecific recognition.
Scheerer P; Kramer A; Otte L; Seifert M; Wessner H; Scholz C; Krauss N; Schneider-Mergener J; Höhne W
J Mol Recognit; 2007; 20(4):263-74. PubMed ID: 17712773
[TBL] [Abstract][Full Text] [Related]
30. Towards the generation of artificial O6-alkylguanine-DNA alkyltransferases: in vitro selection of antibodies with reactive cysteine residues.
Damoiseaux R; Schultz PG; Johnsson K
Chembiochem; 2002 Jun; 3(6):573-5. PubMed ID: 12325014
[No Abstract] [Full Text] [Related]
31. Identification and characterization of immunodominant B-cell epitope of the C-terminus of protective antigen of Bacillus anthracis.
Kaur M; Chug H; Singh H; Chandra S; Mishra M; Sharma M; Bhatnagar R
Mol Immunol; 2009 Jun; 46(10):2107-15. PubMed ID: 19356802
[TBL] [Abstract][Full Text] [Related]
32. Anti-estradiol-17beta single-chain Fv fragments: Generation, characterization, gene randomization, and optimized phage display.
Kobayashi N; Kato Y; Oyama H; Taga S; Niwa T; Sun P; Ohtoyo M; Goto J
Steroids; 2008 Dec; 73(14):1485-99. PubMed ID: 18824188
[TBL] [Abstract][Full Text] [Related]
33. Evaluation of selectivity in homologous multimodal chromatographic systems using in silico designed antibody fragment libraries.
Karkov HS; Woo J; Krogh BO; Ahmadian H; Cramer SM
J Chromatogr A; 2015 Dec; 1426():102-9. PubMed ID: 26654254
[TBL] [Abstract][Full Text] [Related]
34. The PA14 domain, a conserved all-beta domain in bacterial toxins, enzymes, adhesins and signaling molecules.
Rigden DJ; Mello LV; Galperin MY
Trends Biochem Sci; 2004 Jul; 29(7):335-9. PubMed ID: 15236739
[No Abstract] [Full Text] [Related]
35. Simulated mutagenesis of the hypervariable loops of a llama VHH domain for the recovery of canonical conformations.
Velez-Vega C; Fenwick MK; Escobedo FA
J Phys Chem B; 2009 Feb; 113(6):1785-95. PubMed ID: 19132876
[TBL] [Abstract][Full Text] [Related]
36. The crystal structure of the pathogenic collagen type II-specific mouse monoclonal antibody CIIC1 Fab: structure to function analysis.
Uysal H; Sehnert B; Nandakumar KS; Böiers U; Burkhardt H; Holmdahl R; Thunnissen MM
Mol Immunol; 2008 Apr; 45(8):2196-204. PubMed ID: 18241923
[TBL] [Abstract][Full Text] [Related]
37. Directed evolution of human T-cell receptors with picomolar affinities by phage display.
Li Y; Moysey R; Molloy PE; Vuidepot AL; Mahon T; Baston E; Dunn S; Liddy N; Jacob J; Jakobsen BK; Boulter JM
Nat Biotechnol; 2005 Mar; 23(3):349-54. PubMed ID: 15723046
[TBL] [Abstract][Full Text] [Related]
38. Cluster and information entropy patterns in immunoglobulin complementarity determining regions.
Culler S; Hsiao TR; Glassy M; Chau PC
Biosystems; 2004 Nov; 77(1-3):195-212. PubMed ID: 15527957
[TBL] [Abstract][Full Text] [Related]
39. Generation and optimization of human antagonistic antibodies against TIMP-1 as potential therapeutic agents in fibrotic diseases.
Brocks B; Kraft S; Zahn S; Noll S; Pan C; Schauer M; Krebs B
Hum Antibodies; 2006; 15(4):115-24. PubMed ID: 17522433
[TBL] [Abstract][Full Text] [Related]
40. Sequencing and quantifying IgG fragments and antigen-binding regions by mass spectrometry.
de Costa D; Broodman I; Vanduijn MM; Stingl C; Dekker LJ; Burgers PC; Hoogsteden HC; Sillevis Smitt PA; van Klaveren RJ; Luider TM
J Proteome Res; 2010 Jun; 9(6):2937-45. PubMed ID: 20387908
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
